Propylene Glycol
Sponsors
Immunogen Inc., University of Miami, New York City Health and Hospitals Corporation, Government College of Dentistry, Indore, The Cleveland Clinic
Conditions
ConstipationGingivitisHealthy Lifetime Non-smokersOrthopedic DisorderPeriodontal DiseasesPeriodontitisPlatinum-sensitive epithelial ovarianPolytrauma
Phase 1
Phase 2
Phase 3
Clinical and Radiographic Evaluation of Hyaluronic Acid Compared to Propylene Glycol as Vehicle for Double Antibiotic Paste in Lesion Sterilization and Tissue Repair Technique for Non-Vital Primary Molars
NCT05116306
Start: 2021-11-30End: 2024-12-31Target: 36Updated: 2021-11-11
2022-501606-35-00 – Randomized, multicenter, open-label, Phase 3 study of mirvetuximab soravtansine in combination with bevacizumab versus bevacizumab alone as maintenance therapy for patients with FRα-high recurrent platinum-sensitive epithelial ovarian, fallopian tube, or primary peritoneal cancers who have not progressed after second-line platinum-based chemotherapy plus bevacizumab (GLORIOSA).
RecruitingCTIS2022-501606-35-01
Start: 2024-02-21Target: 110Updated: 2026-01-21
Unknown Phase
Evaluation of Acute and Subacute Effects of Nicotine Free Electronic Cigarette(NCFE) Vapors
TerminatedNCT02585791
Start: 2017-02-22End: 2019-12-11Updated: 2020-01-14
Comparative Evaluation of Antiplaque and Antigingivitis Efficacy of Ocimum Sanctum (Tulsi) Extract
CompletedNCT03474146
Start: 2017-04-12End: 2017-07-31Updated: 2018-04-17